Search Results - "Vrijmoet, A."

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    1303P Immune-modulating effects on tumor draining lymph nodes following neoadjuvant chemoradiotherapy combined with immunotherapy in patients with T3-4N0-1 NSCLC

    1303P Immune-modulating effects on tumor draining lymph nodes following neoadjuvant chemoradiotherapy combined with immunotherapy in patients with T3-4N0-1 NSCLC by Ulas, E.B., Vrijmoet, A., Koomen, S., Houda, I., Dickhoff, C., Bahce, I., Senan, S., de Gruijl, T.D., Fransen, M., van Maldegem, F., Radonic, T., Schneiders, F.

    Published in Annals of oncology (01-10-2023)
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    950O Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer: The INCREASE trial

    950O Ipilimumab plus nivolumab and chemoradiotherapy followed by surgery in patients with resectable and borderline resectable lung cancer: The INCREASE trial by Bahce, I., Dickhoff, C., Schneiders, F.L., Veltman, J., Heineman, D.J., Hashemi, S., Fransen, M., Vrijmoet, A., Houda, I., Ulas, E., van de Ven, P., Bouwhuis, N., Meijboom, L., Oprea-Lager, D., Garcia Vallejo, J., de Gruijl, T.D., Radonic, T., Senan, S.

    Published in Annals of oncology (01-09-2022)
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: